Developer docs
API playgroundTry for free, no card

Search company profiles

Sonic Genetics

Full company profile

uuid005cjkb

Namestring
Sonic Genetics
Legal namestring
Sonic Genetics
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Sonic Genetics is a genetic testing division and brand of Sonic Healthcare Limited (ASX:SHL), one of Australia's largest medical diagnostic companies, headquartered in Sydney, New South Wales. The company delivers a broad clinical genetic testing portfolio processed through Sonic Laboratories, spanning reproductive health (Non-Invasive Prenatal Testing, Reproductive Carrier Screening, Fetal Rhesus Screening), pharmacogenomics (Sonic Pgx), cancer genetics (Find It hotspot panel, Prosigna breast cancer assay), and testing for familial disorders, immunology, paediatric disorders, haematological and solid malignancies, lactose intolerance, familial hypercholesterolaemia, and DNA relationship verification. Genetic counselling is offered as an adjunct service across categories.

The business operates a hybrid go-to-market model. The primary channel is clinician-directed ordering through the Sonic Healthcare network, where doctors, pathologists, and genetic counsellors request tests via clinician portals, request forms, and specimen collection at Sonic's national collection centre footprint. A direct-to-consumer layer supports self-service ordering and online payment for selected tests, most prominently NIPT, through the company's website. Marketing is split between clinician-facing medical education (Sonic Education platform, electronic newsletters, clinical resources) and patient-facing website content.

Revenue is generated on a fee-for-service basis: per-test billing to patients and healthcare providers, with Medicare rebates supplementing eligible tests including reproductive carrier screening and familial hypercholesterolaemia from November 2023. The company serves two primary customer segments — healthcare professionals (enterprise-style ordering) and individual patients (consumer self-service for selected tests) — across a domestic-only Australian geographic footprint.

Short descriptiontext

Sonic Genetics is a Sydney-based genetic testing division of Sonic Healthcare (ASX:SHL), providing NIPT, reproductive carrier screening, pharmacogenomics, and cancer genetics through Sonic Laboratories. It serves Australian clinicians and patients via clinician-led ordering, DTC NIPT, and Medicare-rebated testing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genetic testing services, prenatal screening tests, reproductive carrier screening, pharmacogenomic testing, cancer genetics diagnostics
Industry5 codes
PRIMARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Genetic Testing Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Genetic Testing Services
TypeSubscription Recurring
Description

Fee-for-service genetic testing delivered through Sonic Laboratories. Revenue generated from test processing fees billed to patients, healthcare providers, and funded through Medicare rebates where eligible.

sonicgenetics.com.au
2Medicare Rebates
TypeSubscription Recurring
Description

Medicare rebates available for specific tests including reproductive carrier screening (cystic fibrosis, spinal muscular atrophy, fragile X syndrome) and familial hypercholesterolaemia testing from November 2023.

sonicgenetics.com.au
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Reproductive Carrier Screening - Medicare Rebated
ModelSubscriptionBilling cadenceOne time/ perpetual license
Notes

Three-gene panel (cystic fibrosis, spinal muscular atrophy, fragile X syndrome) available with Medicare rebate from November 2023.

sonicgenetics.com.au
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1Sonic Pgx
Description

Pharmacogenomic testing panel that helps doctors personalize medication according to patient's genetic variation.

sonicgenetics.com.au
Core offering1 text field

Sonic Genetics delivers clinical genetic testing services through Sonic Laboratories in Australia, spanning reproductive health (NIPT, reproductive carrier screening, fetal Rhesus screening), pharmacogenomics (Sonic Pgx panel), cancer genetics (hotspot panels and Prosigna), familial hypercholesterolaemia, immunology, paediatric, and haematological/solid malignancy testing. Tests are ordered by healthcare professionals or, in the case of NIPT, directly by patients, with Medicare rebates available for eligible indications and genetic counselling offered as a supporting service.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Sonic Genetics provides a comprehensive genetic testing service operating through Sonic Laboratories in Australia. The company offers a portfolio of genetic tests organized into major categories: reproductive health services including Non-invasive Prenatal Testing (NIPT) and Reproductive Carrier Screening (RCS) with Medicare rebates; pharmacogenomics testing (Sonic Pgx panel) for personalized medication; cancer genetics including hotspot panels and Prosigna; and general genetic testing for familial disorders, immunology conditions, paediatric disorders, haematological and solid malignancies. Additional services include DNA relationship testing, lactose intolerance testing, familial hypercholesterolaemia testing, and fetal Rhesus screening. Genetic counselling is available as a supporting service across all test categories.

Product and service14 records
1Non-invasive Prenatal Testing (NIPT)
CategoryReproductive health genetic testing
Description

Blood test performed on expectant mothers that screens for common genetic conditions such as Down syndrome. Also referred to as NIPS or non-invasive prenatal screening. Available to patients via clinician order or self-referral through the Sonic Genetics website payment portal.

2Reproductive Carrier Screening (RCS)
CategoryReproductive health genetic testing
Description

Blood test for parents that identifies if they carry genetic changes (mutations) that could cause certain genetic conditions in their child. Includes three-gene panel (cystic fibrosis, spinal muscular atrophy, fragile X syndrome) eligible for Medicare rebate.

3Pharmacogenomics (Sonic Pgx)
CategoryPharmacogenomic testing
Description

Genetic test (Sonic Pgx panel) that analyzes genes involved in drug metabolism and hypersensitivity, helping clinicians prescribe medications optimally based on patient genetic variation.

4Lactose Intolerance Testing
CategorySpecialised genetic testing
Description

Genetic test to confirm if a person can digest lactose (the sugar in milk and dairy products). Used for diagnosis in both children and adults.

5Cancer Genetics
CategoryOncology genetic testing
Description

Genetic testing services for cancer risk assessment and characterisation, including the Find It cancer hotspot panel and the Prosigna assay for breast cancer prognosis.

6Familial Hypercholesterolaemia (FH) Testing
CategoryInherited disorder genetic testing
Description

Genetic testing for familial hypercholesterolaemia with Medicare rebate available, supporting diagnosis and management of inherited high cholesterol.

7DNA Relationship Testing
CategoryGenetic identity testing
Description

DNA testing to accurately determine biological relationships for families and individuals, including paternity and other relationship testing.

8Familial Disorders Testing
CategoryInherited disorder genetic testing
Description

Genetic testing to identify inherited conditions, supporting early diagnosis and informed patient care for familial disorders.

9Immunology Testing
CategorySpecialised genetic testing
Description

Analysis of genes modifying the risk of disease or responsible for familial disorders of the immune system.

10Oncology - Haematological Malignancies Testing
CategoryOncology genetic testing
Description

Genetic tests to help clinicians characterise attributes of blood cancers and guide therapy and patient management.

11Oncology - Solid Malignancies Testing
CategoryOncology genetic testing
Description

Assays providing information beyond histological examination to help guide diagnosis, therapy, and monitoring of solid tumour cancers.

12Paediatric Disorders Testing
CategorySpecialised genetic testing
Description

Genetic testing for paediatric disorders to identify conditions early and support diagnosis, treatment, and care for children.

13Genetic Counselling
CategoryGenetic counselling services
Description

Professional genetic counselling services to help patients understand test results, make informed decisions, and cope with genetic conditions.

14Fetal Rhesus Screening
CategoryReproductive health genetic testing
Description

Screening for fetal Rhesus status in Rh-D negative pregnant patients, with Medicare rebate available for non-alloimmunised patients from 11-weeks gestation.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Invitae (now part of Labcorp) offers comprehensive germline genetic testing across reproductive, cancer, and paediatric indications. Highly comparable to Sonic Genetics' broad test menu and clinician-ordering business model.

TypeDirect peer
Description

Myriad is a US genetic testing company focused on hereditary cancer (BRACAnalysis, myRisk), pharmacogenomics, and prenatal screening. Closely comparable to Sonic Genetics' cancer genetics and PGx portfolio, addressing similar clinician-driven demand for personalised medicine.

TypeDirect peer
Description

Natera is a US-based genetic testing company specialising in reproductive health (NIPT via Panorama), oncology, and organ transplant monitoring. Directly comparable to Sonic Genetics on NIPT and reproductive carrier screening offerings and competes for the same clinician ordering channel globally.

TypeBroad incumbent
Description

Labcorp is a large US clinical laboratory network offering a broad menu including reproductive, oncology, and pharmacogenomic genetic tests. Comparable as a broad incumbent with overlapping capabilities and similar B2B clinician ordering motion.

TypeRegional player
Description

Australian Clinical Labs is a major Australian pathology provider offering genetic and specialty diagnostics. Comparable as a domestic competitor for clinician-ordered genetic testing within the same Australian geography.

TypeDirect peer
Description

Exact Sciences (which acquired Genomic Health, the maker of Oncotype DX) operates in oncology molecular diagnostics, comparable to Sonic Genetics' Prosigna breast cancer prognosis offering and broader cancer-genetics franchise.

TypeRegional player
Description

Healius operates one of Australia's largest pathology networks (Laverty, QML, Dorevitch) and competes directly with Sonic Healthcare for clinician-ordered diagnostics. A regional peer because it serves the same Australian market with overlapping reproductive and general pathology services.

TypeEmerging player
Description

GeneDx (acquired by Sema4, now publicly traded) focuses on rare-disease, paediatric, and hereditary genetic testing. Comparable to Sonic Genetics' paediatric and familial-disorder test menu, though with a US-centric operating base.

TypeBroad incumbent
Description

Quest Diagnostics is a major US clinical laboratory providing routine and specialty genetic testing (including NIPT and hereditary cancer panels). Comparable as a broad-incumbent lab services peer with similar payer relationships and clinician channel.

TypeBroad incumbent
Description

Eurofins operates a global network of clinical diagnostics and genetics laboratories, including reproductive and hereditary testing. Comparable as a broad incumbent genetic testing services provider with much greater geographic scale.

Market position
Competitive moat3 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sonic Genetics

Genetic Testing Servicessonicgenetics.com.au

Sonic Genetics is a Sydney-based genetic testing division of Sonic Healthcare (ASX:SHL), providing NIPT, reproductive carrier screening, pharmacogenomics, and cancer genetics through Sonic Laboratories. It serves Australian clinicians and patients via clinician-led ordering, DTC NIPT, and Medicare-rebated testing.

What Sonic Genetics does

Sonic Genetics is a genetic testing division and brand of Sonic Healthcare Limited (ASX:SHL), one of Australia's largest medical diagnostic companies, headquartered in Sydney, New South Wales. The company delivers a broad clinical genetic testing portfolio processed through Sonic Laboratories, spanning reproductive health (Non-Invasive Prenatal Testing, Reproductive Carrier Screening, Fetal Rhesus Screening), pharmacogenomics (Sonic Pgx), cancer genetics (Find It hotspot panel, Prosigna breast cancer assay), and testing for familial disorders, immunology, paediatric disorders, haematological and solid malignancies, lactose intolerance, familial hypercholesterolaemia, and DNA relationship verification. Genetic counselling is offered as an adjunct service across categories.

The business operates a hybrid go-to-market model. The primary channel is clinician-directed ordering through the Sonic Healthcare network, where doctors, pathologists, and genetic counsellors request tests via clinician portals, request forms, and specimen collection at Sonic's national collection centre footprint. A direct-to-consumer layer supports self-service ordering and online payment for selected tests, most prominently NIPT, through the company's website. Marketing is split between clinician-facing medical education (Sonic Education platform, electronic newsletters, clinical resources) and patient-facing website content.

Revenue is generated on a fee-for-service basis: per-test billing to patients and healthcare providers, with Medicare rebates supplementing eligible tests including reproductive carrier screening and familial hypercholesterolaemia from November 2023. The company serves two primary customer segments — healthcare professionals (enterprise-style ordering) and individual patients (consumer self-service for selected tests) — across a domestic-only Australian geographic footprint.

Sonic Genetics firmographics

Firmographics
Name
Sonic Genetics
Legal name
Sonic Genetics
Website
https://sonicgenetics.com.au
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Sonic Genetics is a Sydney-based genetic testing division of Sonic Healthcare (ASX:SHL), providing NIPT, reproductive carrier screening, pharmacogenomics, and cancer genetics through Sonic Laboratories. It serves Australian clinicians and patients via clinician-led ordering, DTC NIPT, and Medicare-rebated testing.
Ownership category
akta.pro rank

Sonic Genetics industry classification

Industry
Product category
Genetic Testing Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)

Keywords

  • Genetic testing services
  • Prenatal screening tests
  • Reproductive carrier screening
  • Pharmacogenomic testing
  • Cancer genetics diagnostics

Where Sonic Genetics is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Sonic Genetics business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Genetic Testing Services: Fee-for-service genetic testing delivered through Sonic Laboratories. Revenue generated from test processing fees billed to patients, healthcare providers, and funded through Medicare rebates where eligible.
  2. Medicare Rebates: Medicare rebates available for specific tests including reproductive carrier screening (cystic fibrosis, spinal muscular atrophy, fragile X syndrome) and familial hypercholesterolaemia testing from November 2023.

Pricing tiers

ModelBillingPrice
SubscriptionOne time/ perpetual licenseReproductive Carrier Screening - Medicare Rebated

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Sonic Genetics product offering

Product offering

Core offering

Sonic Genetics delivers clinical genetic testing services through Sonic Laboratories in Australia, spanning reproductive health (NIPT, reproductive carrier screening, fetal Rhesus screening), pharmacogenomics (Sonic Pgx panel), cancer genetics (hotspot panels and Prosigna), familial hypercholesterolaemia, immunology, paediatric, and haematological/solid malignancy testing. Tests are ordered by healthcare professionals or, in the case of NIPT, directly by patients, with Medicare rebates available for eligible indications and genetic counselling offered as a supporting service.

Product overview

Sonic Genetics provides a comprehensive genetic testing service operating through Sonic Laboratories in Australia. The company offers a portfolio of genetic tests organized into major categories: reproductive health services including Non-invasive Prenatal Testing (NIPT) and Reproductive Carrier Screening (RCS) with Medicare rebates; pharmacogenomics testing (Sonic Pgx panel) for personalized medication; cancer genetics including hotspot panels and Prosigna; and general genetic testing for familial disorders, immunology conditions, paediatric disorders, haematological and solid malignancies. Additional services include DNA relationship testing, lactose intolerance testing, familial hypercholesterolaemia testing, and fetal Rhesus screening. Genetic counselling is available as a supporting service across all test categories.

Differentiator

Problem solved

Functional benefit

Brands

  • Sonic Pgx: Pharmacogenomic testing panel that helps doctors personalize medication according to patient's genetic variation.

Products and services

  • Non-invasive Prenatal Testing (NIPT) Blood test performed on expectant mothers that screens for common genetic conditions such as Down syndrome. Also referred to as NIPS or non-invasive prenatal screening. Available to patients via clinician order or self-referral through the Sonic Genetics website payment portal.
  • Reproductive Carrier Screening (RCS) Blood test for parents that identifies if they carry genetic changes (mutations) that could cause certain genetic conditions in their child. Includes three-gene panel (cystic fibrosis, spinal muscular atrophy, fragile X syndrome) eligible for Medicare rebate.
  • Pharmacogenomics (Sonic Pgx) Genetic test (Sonic Pgx panel) that analyzes genes involved in drug metabolism and hypersensitivity, helping clinicians prescribe medications optimally based on patient genetic variation.
  • Lactose Intolerance Testing Genetic test to confirm if a person can digest lactose (the sugar in milk and dairy products). Used for diagnosis in both children and adults.
  • Cancer Genetics Genetic testing services for cancer risk assessment and characterisation, including the Find It cancer hotspot panel and the Prosigna assay for breast cancer prognosis.
  • Familial Hypercholesterolaemia (FH) Testing Genetic testing for familial hypercholesterolaemia with Medicare rebate available, supporting diagnosis and management of inherited high cholesterol.
  • DNA Relationship Testing DNA testing to accurately determine biological relationships for families and individuals, including paternity and other relationship testing.
  • Familial Disorders Testing Genetic testing to identify inherited conditions, supporting early diagnosis and informed patient care for familial disorders.
  • Immunology Testing Analysis of genes modifying the risk of disease or responsible for familial disorders of the immune system.
  • Oncology - Haematological Malignancies Testing Genetic tests to help clinicians characterise attributes of blood cancers and guide therapy and patient management.
  • Oncology - Solid Malignancies Testing Assays providing information beyond histological examination to help guide diagnosis, therapy, and monitoring of solid tumour cancers.
  • Paediatric Disorders Testing Genetic testing for paediatric disorders to identify conditions early and support diagnosis, treatment, and care for children.
  • Genetic Counselling Professional genetic counselling services to help patients understand test results, make informed decisions, and cope with genetic conditions.
  • Fetal Rhesus Screening Screening for fetal Rhesus status in Rh-D negative pregnant patients, with Medicare rebate available for non-alloimmunised patients from 11-weeks gestation.

Companies that use Sonic Genetics

Customer profile

Segments2 records

Ideal customer profiles2 records

Sonic Genetics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Sonic Genetics partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Sonic Genetics competitors and assessment

Company assessment

Direct peers

  • Invitae: Invitae (now part of Labcorp) offers comprehensive germline genetic testing across reproductive, cancer, and paediatric indications. Highly comparable to Sonic Genetics' broad test menu and clinician-ordering business model.
  • Myriad Genetics: Myriad is a US genetic testing company focused on hereditary cancer (BRACAnalysis, myRisk), pharmacogenomics, and prenatal screening. Closely comparable to Sonic Genetics' cancer genetics and PGx portfolio, addressing similar clinician-driven demand for personalised medicine.
  • Natera: Natera is a US-based genetic testing company specialising in reproductive health (NIPT via Panorama), oncology, and organ transplant monitoring. Directly comparable to Sonic Genetics on NIPT and reproductive carrier screening offerings and competes for the same clinician ordering channel globally.
  • Exact Sciences (Genomic Health): Exact Sciences (which acquired Genomic Health, the maker of Oncotype DX) operates in oncology molecular diagnostics, comparable to Sonic Genetics' Prosigna breast cancer prognosis offering and broader cancer-genetics franchise.

Broad incumbents

  • Labcorp (Laboratory Corporation of America): Labcorp is a large US clinical laboratory network offering a broad menu including reproductive, oncology, and pharmacogenomic genetic tests. Comparable as a broad incumbent with overlapping capabilities and similar B2B clinician ordering motion.
  • Quest Diagnostics: Quest Diagnostics is a major US clinical laboratory providing routine and specialty genetic testing (including NIPT and hereditary cancer panels). Comparable as a broad-incumbent lab services peer with similar payer relationships and clinician channel.
  • Eurofins Genoma / Eurofins Genomics: Eurofins operates a global network of clinical diagnostics and genetics laboratories, including reproductive and hereditary testing. Comparable as a broad incumbent genetic testing services provider with much greater geographic scale.

Regional players

  • Australian Clinical Labs: Australian Clinical Labs is a major Australian pathology provider offering genetic and specialty diagnostics. Comparable as a domestic competitor for clinician-ordered genetic testing within the same Australian geography.
  • Healius (formerly Primary Health Care): Healius operates one of Australia's largest pathology networks (Laverty, QML, Dorevitch) and competes directly with Sonic Healthcare for clinician-ordered diagnostics. A regional peer because it serves the same Australian market with overlapping reproductive and general pathology services.

Emerging players

  • GeneDx: GeneDx (acquired by Sema4, now publicly traded) focuses on rare-disease, paediatric, and hereditary genetic testing. Comparable to Sonic Genetics' paediatric and familial-disorder test menu, though with a US-centric operating base.

Market position

Competitive moat3 records

Key highlights6 records

Customer concentration

Sonic Genetics social profiles

Digital presence

Sonic Genetics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sonic Genetics leadership team

Management profile

Number of profiles

Sonic Genetics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sonic Genetics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sonic Genetics

What does Sonic Genetics do?

Sonic Genetics delivers clinical genetic testing services through Sonic Laboratories in Australia, spanning reproductive health (NIPT, reproductive carrier screening, fetal Rhesus screening), pharmacogenomics (Sonic Pgx panel), cancer genetics (hotspot panels and Prosigna), familial hypercholesterolaemia, immunology, paediatric, and haematological/solid malignancy testing. Tests are ordered by healthcare professionals or, in the case of NIPT, directly by patients, with Medicare rebates available for eligible indications and genetic counselling offered as a supporting service.

Is Sonic Genetics a public or private company?

Sonic Genetics is a private company. It is classified as corporate owned and is currently operating.

When was Sonic Genetics founded?

Sonic Genetics was founded in -1. It employs 1 to 10 people.

Where is Sonic Genetics based?

Sonic Genetics is headquartered in Sydney, Australia, in the Oceania region.

How does Sonic Genetics make money?

Two revenue lines are on record. Clinical Genetic Testing Services are the primary driver. The others are medicare Rebates.

Who are Sonic Genetics's main competitors?

Direct peers on record are Invitae, Myriad Genetics, Natera and Exact Sciences (Genomic Health). Broad incumbents are Labcorp (Laboratory Corporation of America), Quest Diagnostics and Eurofins Genoma / Eurofins Genomics. Regional players are Australian Clinical Labs and Healius (formerly Primary Health Care). GeneDx is listed as an emerging player.

Does Sonic Genetics have an API?

No public API is recorded for Sonic Genetics.

What industry is Sonic Genetics in?

Sonic Genetics's product category is Genetic Testing Services. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLAFAMAH, Genetic & Prenatal Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales